Trials / Completed
CompletedNCT03912571
Sleep Disordered Breathing and Alzheimer's Disease Biomarkers in Normal Aging and Mild Cognitive Impairment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 28 (actual)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 55 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the sleep patterns of subjects with or without sleep disturbances (insomnia, sleep apnea) and compare these findings with their previous FDG/PIB PET, structural MRI and brain blood flow scams performed during their participation in the Following studies 'Alzheimer's Disease Core Center (ADCC) Clinical Evaluation' (IRB: 2942), MRI Progression Markers of Cognitive Decline in the Elderly' (IRB:09-0586), or 'Imaging Neuro inflammation in Alzheimer's Disease with \[11C\] Arachidonic Acid (AA) and PET'(IRB: 10-00442).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Structural 3T MRI | measures of global and hippocampal atrophy) |
| DIAGNOSTIC_TEST | MRI Based Perfusion Imaging | brain blood flow |
| DIAGNOSTIC_TEST | VR-CO2 MRI Scans | reduced vaso reactivity to carbon dioxide |
Timeline
- Start date
- 2011-11-13
- Primary completion
- 2019-09-01
- Completion
- 2019-09-01
- First posted
- 2019-04-11
- Last updated
- 2021-09-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03912571. Inclusion in this directory is not an endorsement.